Northern Trust Company of Connecticut’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
BIT
Northern Trust Company of Connecticut's BMRN Position: Q4 2013 in Review
Northern Trust Company of Connecticut increased its BioMarin Pharmaceuticals (BMRN) stake by 12% in Q4 2013, buying an estimated $2.42M and bringing the position to 342,894 shares worth $24.1M. The position accounts for 0.15% of the portfolio, ranked #171.
Northern Trust Company of Connecticut first reported a position in BMRN in Q2 2013 and has held it in 3 quarters since. 307 funds tracked by Wall St. Rank hold BMRN as of Q4 2013.
- Northern Trust Company of Connecticut held 342,894 shares of BioMarin Pharmaceuticals worth $24.1M as of Q4 2013.
- Northern Trust Company of Connecticut bought 35,705 BioMarin Pharmaceuticals shares in Q4 2013, an estimated $2.42M.
- BioMarin Pharmaceuticals made up 0.15% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #171 holding.
- Northern Trust Company of Connecticut first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
- 307 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2013.
Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.